BCBS may cover Wegovy for weight loss when patients meet the plan's medical necessity requirements
This medication mimics GLP-1, a hormone that reduces appetite, promoting sustained weight loss
More than three-quarters of patients taking both drugs reported at least one side effect, mostly mild to moderate gastrointestinal issues such as nausea, constipation, diarrhea and vomiting
NegriMGentileAde AngelisCMontTPatalanoRColaoAet al
That said, common clinical patterns include: Reduced hunger and cravings Smaller portion sizes Less emotional and stress eating Gradual, steady fat loss Improved blood sugar control Semaglutide tends to produce consistent, sustainable weight loss , especially for patients who combine treatment with nutrition and lifestyle support
Integration of the transgene was screened by PCR of tail DNA